“…Positive control: included on 20 osteoarthritic rats which left without treatment and were divided equally into mild and severe not treated subgroups according to the detected clinical signs which are pain, swelling and, lameness. Treated group: included on 20 osteoarthritic rats which were divided equally into mild and severe treated groups according to severity of clinical signs and treated orally with copper albumin complex (obtained from Prof. Dr. Ahmed Yassein Nassar, professor of biochemistry, faculty of Medicine, Assiut University, Assiut, Egypt as patent cooperation treaty (PCT) in the international Bureau of World Intellectual Property Organization (WIPO), Geneva, Switzerland / World Organization (WO) 2008 / 028497) for a month at a dose of 1 ml/kg B.W daily after suspension of 817μg/kg copper albumin complex in water (Taha et al, 2022).…”